Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

PURPOSE: Combinations of long-acting bronchodilators are recommended to reduce the rate of COPD exacerbations. Evidence from the DYNAGITO trial showed that the fixed-dose combination of tiotropium + olodaterol reduced the annual rate of total exacerbations (P<0.05) compared with tiotropium monoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogendoorn, Martine, Corro Ramos, Isaac, Baldwin, Michael, Luciani, Laura, Fabron, Cecile, Detournay, Bruno, Rutten-van Mölken, Maureen P M H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388779/
https://www.ncbi.nlm.nih.gov/pubmed/30863045
http://dx.doi.org/10.2147/COPD.S191031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388779/
https://www.ncbi.nlm.nih.gov/pubmed/30863045
http://dx.doi.org/10.2147/COPD.S191031

Ejemplares similares